• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TUTOGEN MEDICAL, GMBH FORTIVA; PORCINE DERMIS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TUTOGEN MEDICAL, GMBH FORTIVA; PORCINE DERMIS Back to Search Results
Lot Number PD17380001
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problems Hypersensitivity/Allergic reaction (1907); Inflammation (1932); Rash (2033); Seroma (2069)
Event Date 08/09/2021
Event Type  Injury  
Manufacturer Narrative
It is unknown at this time if the graft remains implanted.A comprehensive records re-review will be conducted.Once results are available, a follow-up will be submitted.
 
Event Description
Rti surgical, inc and tutogen medical gmbh (tmi), a wholly subsidiary of rti, recevied a complaint on 08/17/2021, as part of the fortiva appear trial.The reported complaint indicated that the patient (subject id (b)(6)) underwent a breast reconstruction on (b)(6) 2021 with implantation of fortiva porcine dermis and developed a seroma on (b)(6) 2021.
 
Manufacturer Narrative
There were no departures noted during records that had a negative impact of the manufacturing of fortiva grafts from lot pd17380001.There were no related complaints for the lot.All fortiva® tissue matrix grafts undergo a validated sterilization methodology; tutoplast®.Manufacturing records indicate that the xenograft implant with serial id (b)(6) manufactured from the lot met all specification requirements at the time of release.
 
Event Description
Follow-up information received on 09/01/2021,stated that the patient reported "redbreast on the right side and exanthema on the whole body.The patient was treated with an antiallergic medication for both the seroma and exanthema.The "redbreast" was treated with antibiotic.Outcome of the event was resolved on (b)(6) 2021.It was clarified that the patient did not have any relevant medical history and no concomitant medications.All three events have been assessed as not serious and are described in the instructions for use (ifu), (exanthema only as allergic reaction).Batch documentation analysis revealed that serial id (b)(6) was manufactured according to al specifications and met all release.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FORTIVA
Type of Device
PORCINE DERMIS
Manufacturer (Section D)
TUTOGEN MEDICAL, GMBH
industriestrabe 6
neunkirchen am brand, germany 91077 , DE
GM  91077, DEU
Manufacturer (Section G)
RTI SURGICAL, INC
11621 research circle
alachua FL 32615
Manufacturer Contact
charity emmons
11621 research circle
alachua, FL 32615
3864188888
MDR Report Key12475619
MDR Text Key271540225
Report Number3002924436-2021-00025
Device Sequence Number1
Product Code FTM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K142070
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/15/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/31/2021
Device Lot NumberPD17380001
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/17/2021
Was Device Evaluated by Manufacturer? No
Date Device Manufactured01/31/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexFemale
-
-